- Home
- WAFU vs CYCN Comparison
WAFU vs CYCN Comparison
Compare WAFU & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFU
- CYCN
- Stock Information
- Founded
- WAFU 1999
- CYCN 2018
- Country
- WAFU China
- CYCN United States
- Employees
- WAFU N/A
- CYCN N/A
- Industry
- WAFU Other Consumer Services
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- WAFU Real Estate
- CYCN Health Care
- Exchange
- WAFU Nasdaq
- CYCN Nasdaq
- Market Cap
- WAFU 7.0M
- CYCN 7.5M
- IPO Year
- WAFU 2019
- CYCN N/A
- Fundamental
- Price
- WAFU $1.60
- CYCN $2.54
- Analyst Decision
- WAFU
- CYCN
- Analyst Count
- WAFU 0
- CYCN 0
- Target Price
- WAFU N/A
- CYCN N/A
- AVG Volume (30 Days)
- WAFU 98.4K
- CYCN 31.9K
- Earning Date
- WAFU 01-01-0001
- CYCN 03-04-2025
- Dividend Yield
- WAFU N/A
- CYCN N/A
- EPS Growth
- WAFU N/A
- CYCN N/A
- EPS
- WAFU N/A
- CYCN N/A
- Revenue
- WAFU $6,374,594.00
- CYCN $2,000,000.00
- Revenue This Year
- WAFU N/A
- CYCN N/A
- Revenue Next Year
- WAFU N/A
- CYCN N/A
- P/E Ratio
- WAFU N/A
- CYCN N/A
- Revenue Growth
- WAFU N/A
- CYCN N/A
- 52 Week Low
- WAFU $1.36
- CYCN $1.27
- 52 Week High
- WAFU $7.49
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- WAFU 44.25
- CYCN 47.88
- Support Level
- WAFU $1.55
- CYCN $2.44
- Resistance Level
- WAFU $1.70
- CYCN $2.68
- Average True Range (ATR)
- WAFU 0.13
- CYCN 0.20
- MACD
- WAFU 0.00
- CYCN 0.02
- Stochastic Oscillator
- WAFU 39.31
- CYCN 39.83
About WAFU Wah Fu Education Group Limited
Wah Fu Education Group Ltd is involved in providing online exam preparation services and related technology solutions and also produces online training course materials in China. It develops online educational materials that are offered through the cloud and that can be used for a wide range of purposes, such as standard examination preparation, professional training, and interactive programs for educational purposes other than exam preparation. Its segments are Online Education Services, and Technological Development and Operation Service. The company generates maximum revenue from the Online Education Services segment.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.